Home

Cocrystal Pharma, Inc. - Common Stock (COCP)

1.9900
0.00 (0.00%)

Cocrystal Pharma Inc. is a biotechnology company focused on the development of innovative antiviral therapies to treat various viral infections

The company utilizes its proprietary drug discovery platform to create novel compounds aimed at inhibiting viral replication and targeting specific viral targets. Cocrystal Pharma is particularly engaged in research related to hepatitis and influenza, striving to address unmet medical needs in the field of infectious diseases. Through its scientific advancements and strategic partnerships, the company aims to deliver effective treatments that can significantly improve patient outcomes.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close1.990
Open2.040
Bid1.960
Ask2.190
Day's Range1.990 - 2.080
52 Week Range1.325 - 3.260
Volume6,396
Market Cap20.25M
PE Ratio (TTM)-1.363
EPS (TTM)-1.5
Dividend & YieldN/A (N/A)
1 Month Average Volume32,969

News & Press Releases

12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 31, 2024
Dow Dips Over 100 Points; Cocrystal Pharma Shares Slidebenzinga.com
Via Benzinga · December 31, 2024
Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummetbenzinga.com
Via Benzinga · December 31, 2024
US Stocks Open Higher; House Prices Increase In Octoberbenzinga.com
Via Benzinga · December 31, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 26, 2024
Recap: Cocrystal Pharma Q4 Earningsbenzinga.com
Via Benzinga · March 28, 2024
Recap: Cocrystal Pharma Q3 Earningsbenzinga.com
Via Benzinga · November 13, 2023
Analyst Ratings for Cocrystal Pharmabenzinga.com
Via Benzinga · August 15, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 5, 2024
Toll Brothers To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursdaybenzinga.com
Via Benzinga · August 22, 2024
CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event
NEW YORK, NY / ACCESSWIRE / August 15, 2024 / CoCrystal Pharma (NASDAQCOCP), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses and noroviruses, announces that management will present a company overview at the virtual Investor Summit Microcap Forum being held Tuesday, August 20, 2024. Management will be available for 1-on-1 meetings throughout the day.
Via ACCESSWIRE · August 15, 2024
COCP Stock Earnings: Cocrystal Pharma Misses EPS for Q2 2024investorplace.com
COCP stock results show that Cocrystal Pharma missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 14, 2024
COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q1 2024investorplace.com
COCP stock results show that Cocrystal Pharma beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 13, 2024
Why Cocrystal Pharma Shares Are Trading Higher Todaybenzinga.com
Cocrystal Pharma (NASDAQCOCP) shares are trading higher after the company completed a $4 million private placement.
Via Benzinga · April 10, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 10, 2024
COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q4 2023investorplace.com
COCP stock results show that Cocrystal Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 28, 2024
Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value Catalysts in New CEO Video Interview on Planet MicroCap
LOS ANGELES, CA / ACCESSWIRE / March 5, 2024 / Planet MicroCap today published a new Video Interview with Jim Martin, Co-CEO and CFO, from Cocrystal Pharma, Inc. (NASDAQCOCP), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2) noroviruses and hepatitis C viruses, according to the company's website (see here: https://www.cocrystalpharma.com/).
Via ACCESSWIRE · March 5, 2024
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · November 16, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · November 15, 2023
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Sessionbenzinga.com
Gainers PLx Pharma Inc. (NASDAQPLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday.
Via Benzinga · April 10, 2023
$2M Bet On Cocrystal Pharma? Check Out These 3 Penny Stocks Insiders Are Aggressively Buyingbenzinga.com
The Dow Jones closed slightly higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · April 10, 2023
Why Pioneer Natural Resources Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarketbenzinga.com
Gainers PLx Pharma Inc. (NASDAQPLXP) jumped 149.6% to $0.2623 in pre-market trading after dropping over 13% on Thursday.
Via Benzinga · April 10, 2023
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · April 7, 2023
Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarketbenzinga.com
Gainers Inpixon (NASDAQINPX) shares rose 41% to $2.20 in pre-market trading after gaining 6% on Tuesday. Inpixon, last month, secured a purchase order valued at over $1m for its RTLS products from a leading transportation and industrial equipment provider.
Via Benzinga · January 25, 2023
Cocrystal Pharma Discusses Clinical Progress and Significance of Its Novel Antiviral Therapeutics Pipeline with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - January 23, 2023) - The Stock Day Podcast welcomed Cocrystal Pharma, Inc. (NASDAQCOCP) ("Cocrystal," "Cocrystal...
Via Newsfile · January 23, 2023